GAMMADELTA THERAPEUTICS LTD

Company number 10238425

Date	Type	Description	View / Download
19 Feb 2024	CH01	Director's details changed for Ms Seyda Atadan Memis on 1 September 2023	(2 pages)
11 Jan 2024	AD02	Register inspection address has been changed from 100 New Bridge Street London EC4V 6JA United Kingdom to 280 Bishopsgate London EC2M 4RB	(1 page)
22 Jun 2023	AD03	Register(s) moved to registered inspection location 100 New Bridge Street London EC4V 6JA	(1 page)
21 Jun 2023	AD02	Register inspection address has been changed to 100 New Bridge Street London EC4V 6JA	(1 page)
21 Jun 2023	CS01	Confirmation statement made on 16 June 2023 with updates	(12 pages)
26 Jan 2023	TM01	Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023	(1 page)
03 Jan 2023	AA	Group of companies' accounts made up to 31 March 2022	(43 pages)
10 Nov 2022	TM01	Termination of appointment of Mark Gibbons as a director on 8 November 2022	(1 page)
29 Sep 2022	TM01	Termination of appointment of Heather Adkins Huet as a director on 22 July 2022	(1 page)
23 Aug 2022	AP01	Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022	(2 pages)
11 Aug 2022	SH01	Statement of capital following an allotment of shares on 1 August 2022 GBP 6,942.418	(6 pages)
11 Aug 2022	MA	Memorandum and Articles of Association	(27 pages)
11 Aug 2022	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES13 ‐ Company business 01/08/2022 RES01 ‐ Resolution of adoption of Articles of Association	(3 pages)
11 Aug 2022	SH10	Particulars of variation of rights attached to shares	(2 pages)
09 Aug 2022	MR04	Satisfaction of charge 102384250001 in full	(1 page)
20 Jul 2022	CS01	Confirmation statement made on 16 June 2022 with updates	(10 pages)
22 Apr 2022	SH01	Statement of capital following an allotment of shares on 5 April 2022 GBP 6,942.416	(4 pages)
20 Apr 2022	AP01	Appointment of Dr Emma Jane Roffe as a director on 5 April 2022	(2 pages)
20 Apr 2022	AP01	Appointment of Mr Jonathan Clark Neal as a director on 5 April 2022	(2 pages)
19 Apr 2022	PSC05	Change of details for Takeda Pharmaceutical Company Limited as a person with significant control on 5 April 2022	(2 pages)
19 Apr 2022	PSC07	Cessation of Abingworth Bioventures Vi Gp Lp as a person with significant control on 5 April 2022	(1 page)
19 Apr 2022	TM01	Termination of appointment of Paolo Paoletti as a director on 5 April 2022	(1 page)
19 Apr 2022	TM01	Termination of appointment of Michael John Owen as a director on 5 April 2022	(1 page)
19 Apr 2022	TM01	Termination of appointment of Adrian Clive Hayday as a director on 5 April 2022	(1 page)
19 Apr 2022	TM01	Termination of appointment of Peter Neville Goodfellow as a director on 5 April 2022	(1 page)